|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Correlation between Saccharomyces cerevisiae DNA in intestinal mucosal samples and anti-Saccharomyces cerevisiae antibodies in serum of patients with IBD显示文摘瞄准:调查在粘膜 S 的 ASCA 和存在之间的关联。在 CD, ulcerative (UC ) 病人和控制的一张人口的啤酒 DNA。方法:S。cerevisiae 特定的教材和一根荧光灯的探针为 5' exonuclease 实时 PCR (TaqMan ) 试金被设计,它是用为在实时的 PCR 产品的察觉的一根荧光灯标签的探针的一个同质的系统。我们在一组 76 煽动性的肠疾病(IBD ) 与 ASCA 调查结果分析了 PCR 结果的关系病人(31 CD, 45 UC ) 并且 22 健康控制(HC ) 。结果:ASCA (IgA 或 IgG ) 在 19 是积极的(61%) 有 CD 的病人, 12 (27%) 与 HC 的 UC 和没有。PCR 扩大在 10 从最后的结果被禁止并且排除(22%) UC 病人, 7 (22%) CD 病人,并且 6 (30%) HC。在里面仅仅, 15 粘膜取样, S。啤酒 DNA 被实时 PCR 检测,包括 7 (29%) 在 CD, 7 (19%) 在 UC, 1 (6%) 在 HC。在 4 CD 并且在 4 个 UC 病人, ASCA 和粘膜 S。啤酒是积极的。粘膜 S。啤酒在 3 UC,和 3 个 CD 病人在有否定 ASCA IgA 和 IgG 的联合是在场的。结论:自从 S 的存在,我们结束那。在结肠的粘膜活体检视标本的啤酒是很稀罕的, ASCA 是不大可能的被连续暴露向 S 解释。在粘膜的啤酒。因此, ASCA 形成必须在生命更早发生,层次在免疫学的此后仍然保持相对稳定易受影响的人。 | RC Mallant-Hent M Mooij BME von Blomberg RK Linskens AA van Bodegraven PHM Savelkoul | 2006 | World Journal of Gastroenterology2006，12，2： | 2 |
| 2 | Predictive value of inflammatory an d coagulation parameters in the course of severe ulcerative colitis显示文摘 | Linskens RK van Bodegraven AA Schoorl M | 2001 | Dig Dis Sci2001，46，3： | 1 |
| 3 | Diagnosis andtreatment of ( disease - related ) in - hospital malnutrition : the performance of medical and nursing staff显示文摘 | Bavelaar JW Otter CD van Bodegraven AA | 2008 | Clinical Nutrition2008，27，3： | 1 |
| 4 | Laparo- scopic ileocolic resection versus infliximab treatment of distal ileitis in Crohn's disease: a randomized muhicenter trial 显示文摘 | Eshuis EJ Bemelman WA van Bodegraven AA | 2008 | BMC Surg2008，8，1： | 1 |
| 5 | Gallbladder contents and fasting gallbladder volumes during and after pregnancy 显示文摘 | Van Bodegraven AA Bohmer C J Manoliu RA | 1998 | Scand J Gastroenterol1998，33，9： | 1 |
| 6 | Guidelines for treatment with infliximab for Crohn's disease显示文摘 | Hommes DW Oldenburg B Van Bodegraven AA | | 0，，02： | 1 |
| 7 | Hemostatie imbalance in active and quiescent ulcerative colitis显示文摘 | Van Bodegraven AA Schoorl M Baak JP | 2001 | Am J Gastroenterol2001，96，4： | 1 |
| 8 | Drug Insight: pharmacology and toxicity of thiopurine therapy in patients with IBD 显示文摘 | de Boer NK van Bodegraven AA Jharap B | 2007 | Nat Clin Pract Gastroenterol Hepatol2007，4，12： | 1 |
| 9 | Probiotics ( VSL#3 ) in arthralgia in patients with ulcerative colitis and Crohn's disease: a pilot study显示文摘 | Karimi O Pena AS van Bodegraven AA | 2005 | Drugs Today (Barc)2005，41，： | 1 |
| 10 | Fructo-oligosaccharides and fibre in enteral nutrition has a beneficial influence on microbiota and gastrointestinalquality of life显示文摘 | Wierdsma NJ van Bodegraven AA Uitdehaag BM | 2009 | Scand J Gastroenterol2009，44，7： | 1 |
| 11 | Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of NI-0401 ( a fully human anti-CD3 monoclonal antibody) in patients with moderate to severe active Crohn' s disease显示文摘 | van der Woude C J Stokkers P van Bodegraven AA | 2010 | Intlamm Bowel Dis2010，16，10： | 1 |
| 12 | A NFKB1 promoter polymorphism is involved in susceptibility to ulcerative colitis显示文摘 | Borm ME van Bodegraven AA Mulder CJ Kraal G Bouma G | 2005 | Int J Immunogenet2005，32，6： | 1 |
| 13 | Probiotics( VSL#3 ) in arthralgia in patients with ulcerative colitis and Crohn's disease: a pilot study 显示文摘 | Karimi O Pena AS van Bodegraven AA | 2005 | Drugs Today ( Bare )2005，41，7： | 1 |
| 14 | Diagnosis and treatment of ( disease-related ) in-hospital malnutrition : the performance of medical and nursing staff显示文摘 | Bavelaar JW Otter CD van Bodegraven AA | 2008 | Clin Nutr2008，27，3： | 1 |
| 15 | Genetic variation in myosin IXB is associated with ulcerative colitis显示文摘 | van Bodegraven AA Curley CR Hunt KA | 2006 | Gastroenterology2006，131，6： | 1 |
| 16 | Guidelines for treatment with infliximab for Crohn's disease 显示文摘 | Hommes DW Oldenburg B Bodegraven van AA | 2006 | Neth J Med2006，64，7： | 1 |
| 17 | Diagnosis and treatment of (disease-related) in-hospital malnutrition: the perform- ance of medical and nursing staff 显示文摘 | Bavelaar JW Otter CD van Bodegraven AA | 2008 | Clin Nutr2008，27，： | 1 |
| 18 | Drug Insight:pharmacology and toxicity of thiopurine therapy in patients with IBD显示文摘 | de Boer NK van Bodegraven AA Jharap B | 2007 | Nat Clin Pract Gastroenterol Hepatol2007，4，12： | 1 |
| 19 | Low-dose oral cyclosporine treatment in steroid-refractory ulcerative colitis:clinical outcome and cyclosporine blood concentrations(abstract)显示文摘 | Linskens RK Van Bodegraven AA Van Haelst IMM | 1997 | Neth J Med1997，50，5： | 1 |
| 20 | Persistent activation of coagulation and fibrinolysis after treatment of active ulcerative colitis显示文摘 | van Bodegraven AA Schoorl M Linskens RK | 2002 | Eur J Gastroenterol Hepatol2002，14，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员